Literature DB >> 34001202

Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals' experiences.

Siv-Elin Leirvaag Carlsen1, Katja Isaksen2, Lars Thore Fadnes1,3, Ole Jørgen Scheie Lygren1, Anne Nordrehaug Åstrøm4,5.   

Abstract

BACKGROUND: People with substance use disorders often have poor oral health, which can negatively impact their quality of life. Since 2005, patients receiving opioid maintenance treatment (OMT) in Norway have been eligible for free oral health care services offered through public oral health clinics. Despite a large need for oral health services amongst patients in OMT, figures suggest that the use of these services is low amongst this patient group. It has been unclear which barriers that contribute to this. This qualitative study explores the underlying barriers to the use of oral health care services amongst patients in OMT, from the perspective of the patients as well as dental health care workers (DHW).
METHODS: Through a combination of focus group interviews and individual interviews, data were collected from 63 participants; 30 patients in OMT and 33 DHW. Thematic analysis identified key themes for the use (or not) of oral health care services amongst patients in OMT.
RESULTS: Both individual and structural barriers prevent OMT patients from using the free oral health care services offered to them. These barriers include struggling to attend appointments, anxiety and fear of dentists, discrepancies between patients' expectations and the services offered and perceived stigma. OMT patients' lack of information regarding their rights and access to oral health services was also a barrier, as was DHWs' lack of knowledge and information of the OMT system and what they can offer patients.
CONCLUSIONS: OMT patients face several barriers in accessing and using oral health care services. However, through a number of relatively simple measures, it is possible that the use of oral health services amongst OMT patients can be increased.

Entities:  

Keywords:  Barriers; Dental health care workers; OMT patients; Opioid maintenance treatment; Oral health

Year:  2021        PMID: 34001202     DOI: 10.1186/s13011-021-00379-6

Source DB:  PubMed          Journal:  Subst Abuse Treat Prev Policy        ISSN: 1747-597X


  40 in total

1.  Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden.

Authors:  Disa Dahlman; Anders Håkansson; Per Björkman; Marianne Alanko Blomé; Alex H Kral
Journal:  Subst Use Misuse       Date:  2015-11-19       Impact factor: 2.164

2.  Outcomes of Patients in Long-Term Opioid Maintenance Treatment.

Authors:  Bettina Zippel-Schultz; Michael Specka; Konrad Cimander; Thomas Eschenhagen; Jörg Gölz; Markus Maryschok; Manfred Nowak; Thomas Poehlke; Heino Stöver; Thomas M Helms; Norbert Scherbaum
Journal:  Subst Use Misuse       Date:  2016-06-29       Impact factor: 2.164

3.  Associations between duration of illicit drug use and health conditions: results from the 2005-2007 national surveys on drug use and health.

Authors:  Beth Han; Joseph C Gfroerer; James D Colliver
Journal:  Ann Epidemiol       Date:  2010-02-19       Impact factor: 3.797

Review 4.  Infectious diseases occurring in the context of substance use disorders: A concise review.

Authors:  Bhanu Prakash Kolla; Tyler Oesterle; Mark Gold; Frederick Southwick; Teresa Rummans
Journal:  J Neurol Sci       Date:  2020-01-31       Impact factor: 3.181

5.  Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.

Authors:  Paola Pedrelli; Nadia Iovieno; Mario Vitali; Enrico Tedeschini; Kate H Bentley; George I Papakostas
Journal:  J Clin Psychopharmacol       Date:  2011-10       Impact factor: 3.153

6.  All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.

Authors:  Knut Boe Kielland; Kjell Skaug; Ellen J Amundsen; Olav Dalgard
Journal:  J Hepatol       Date:  2012-09-04       Impact factor: 25.083

7.  Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment.

Authors:  A J Durante; P A Selwyn; P G O'Connor
Journal:  Addiction       Date:  1998-09       Impact factor: 6.526

8.  Depression, suicidal ideation, and related factors of methadone maintenance treatment users in Guangzhou, China.

Authors:  Xiao Zhang; Huifang Xu; Jing Gu; Joseph T F Lau; Chun Hao; Yuteng Zhao; Alissa Davis; Yuantao Hao
Journal:  AIDS Care       Date:  2016-02-03

9.  Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017.

Authors:  Christer F Aas; Jørn Henrik Vold; Svetlana Skurtveit; Ingvild Odsbu; Fatemeh Chalabianloo; Aaron G Lim; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.